Stage I Ovarian Sertoli-Leydig Cell Tumor in a 19-Year-Old

This ovarian cancer diagnosis at a glance

Stage at diagnosis
Stage I
Sex
female
Treatment
surgery and chemotherapy
Outcome
Care Ongoing

Treatment course, step by step

  1. Fertility-sparing surgery removed the right ovary and fallopian tube with partial omentectomy and peritoneal biopsies.
  2. She then started bleomycin, etoposide, and cisplatin chemotherapy and had completed 4 months of therapy at the time of the report.

What happened, in summary

A 19-year-old woman developed abdominal pain and sudden bloating. Imaging showed a complex mass confined to the right ovary, and her AFP tumor marker was elevated. She also had a striking family history: an older sister had died from ovarian cancer at age 11.

Because the mass appeared suspicious but resectable, she chose fertility-preserving treatment. Surgery removed the right ovary and fallopian tube, along with part of the omentum and several peritoneal biopsies. The tumor had ruptured through its capsule, but no lymph node enlargement or peritoneal implants were found. Pathology identified a poorly differentiated Sertoli-Leydig cell tumor with a very small area of gastrointestinal-type tissue. The report classified the tumor as Stage I because disease remained confined to the ovary despite capsular rupture.

Her AFP level became undetectable after surgery. Given the poor differentiation and heterologous elements, she started bleomycin, etoposide, and cisplatin chemotherapy. At the time of publication, she had completed about 4 months of treatment without major complications.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar ovarian cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more ovarian cancer stories